Literature DB >> 1899657

Intraoperative electron beam radiation therapy (IOEBRT) for carcinoma of the exocrine pancreas.

R R Dobelbower1, A A Konski, H W Merrick, D G Bronn, D Schifeling, C Kamen.   

Abstract

The abdominal cavities of 50 patients were explored in a specially constructed intraoperative radiotherapy operating amphitheater at the Medical College of Ohio. Twenty-six patients were treated with intraoperative and postoperative precision high dose external beam therapy, 12 with intraoperative irradiation but no external beam therapy, and 12 with palliative surgery alone. All but two patients completed the postoperative external beam radiation therapy as initially prescribed. The median survival time for patients treated with palliative surgery alone was 4 months, and that for patients treated with intraoperative radiotherapy without external beam therapy was 3.5 months. Patients undergoing intraoperative irradiation and external beam radiation therapy had a median survival time of 10.5 months. Four patients died within 30 days of surgery and two patients died of gastrointestinal hemorrhage 5 months posttreatment.

Entities:  

Mesh:

Year:  1991        PMID: 1899657     DOI: 10.1016/0360-3016(91)90146-u

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  6 in total

Review 1.  Current management of pancreatic carcinoma.

Authors:  K D Lillemoe
Journal:  Ann Surg       Date:  1995-02       Impact factor: 12.969

Review 2.  Modern surgical treatment of pancreatic cancer.

Authors:  H Ozaki
Journal:  Int J Pancreatol       Date:  1994 Oct-Dec

3.  [3D-Ct-planned interstitial HDR brachytherapy + percutaneous irradiation and chemotherapy in inoperable pancreatic carcinoma. Methods and clinical outcome].

Authors:  L Pfreundner; K Baier; F Schwab; J Willner; K Bratengeier; M Flentje; H Feustel; K H Fuchs
Journal:  Strahlenther Onkol       Date:  1998-03       Impact factor: 3.621

4.  Pain management of patients with unresectable peripancreatic carcinoma.

Authors:  Rutger C I van Geenen; Claudia M G Keyzer-Dekker; Geertjan van Tienhoven; Huug Obertop; Dirk J Gouma
Journal:  World J Surg       Date:  2002-03-26       Impact factor: 3.352

5.  5-Fluorouracil plus 5-methyltetrahydrofolate in advanced pancreatic cancer. GLISP (Gruppo Ligure Studio Pancreas).

Authors:  E Bolli; S Saccomanno; G Mondini; C Aschele; A Guglielmi; B Ligas; M Connio; A Mori; R Rosso; A Sobrero
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

6.  ESTRO IORT Task Force/ACROP recommendations for intraoperative radiation therapy in borderline-resected pancreatic cancer.

Authors:  Felipe A Calvo; Jose M Asencio; Falk Roeder; Robert Krempien; Philip Poortmans; Frank W Hensley; Marco Krengli
Journal:  Clin Transl Radiat Oncol       Date:  2020-05-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.